News

The researchers conducted a one-year investigation at two Level I trauma centers in South Florida, analyzing data from 2,686 adults aged 65 and older admitted after fall-related head injuries.

Researchers have demonstrated a novel vaccine delivery method in an animal model, utilizing dental floss to administer the vaccine to the tissue between the teeth. The new technique stimulated the production of antibodies in mucosal surfaces.

Researchers from Chungnam National University examined how vitamin D influences liver repair mechanisms in chronic liver disease.

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various cell types.

Researchers at Penn State and the World Health Organization have developed a method to predict measles vaccination levels using routinely collected clinical data on suspected measles cases.

Researchers have discovered how a hormone interacts with a receptor on the surface of immune cells to shield cancer cells from the body’s natural defenses.

Guselkumab, a medication with a mechanism of action that is new to inflammatory bowel disease (IBD) treatment, outperformed an established standard of care in promoting intestinal healing and symptom relief.

The candidate, TherVacB, developed through research led by Helmholtz Munich, is now being evaluated in a multi-site phase 1b/2a trial. The first patient was enrolled in June 2025.

Researchers have discovered that immune cells are the unexpected source of a protein called FAS-ligand, which has undermined the cancer-fighting ability of engineered cell therapies.

Scientists report that a class of drugs, called RNA interference (RNAi) therapeutics, represent a major advancement in the treatment of chronic HBV infections, expanding treatment strategies.